Sprachauswahl: Pharma-Kongress - Deutschsprachige Version der Website DE | Pharma Congress - Switch to the English version of the website EN

Referenten

 

Wie immer auf dem Pharma-Kongress diskutieren Sie die aktuellen Trends und Herausforderungen mit Referenten aus den führenden europäischen Pharma-Unternehmen, aus Behörden sowie von Universitäten.

Referenten des Pharma-Kongresses 2019:

  • Ib Alstrup, Danish Medicines Agency
    Medicines Inspector.
  • Gabriel Anderson, Novartis
    Co-lead Novartis's visual inspection expert Network.
  • Dr. Abdulaziz Awad, Saudi Biotechnology Manufacturing Company
    Board Member and CEO.
  • Eva-Maria Baumgartner, Syntacoll
    Validation Manager.
  • Dr. Matthias Beck, Oncotec
    Manager New Business Development.
  • Stefan Bieler, IDT-Biologika
    Process engineer at IDT-Biologika, Department Filling and Freeze Drying Vaccines.
  • Maximilian Bischl, Roche Diagnostics
    Manager Operations.
  • Mario Bott, IPA Fraunhofer
    Corporate Project Manager, Leistungszentrum für personalisierte Produktion.
  • Dr. Berthold Düthorn, Robert Bosch Packaging Technology
    Vice President.
  • Zinaid Dzinovic, Novartis
    Program Manager MES.
  • Klaus Eichmüller, Wolnzach, c/o Regional Council Darmstadt, GMP Inspectorate, Germany
    Head of Inspectorate.
  • Dr. Detlef Eisenkraetzer, Roche Diagnostics
    Director Fermentation Development.
  • Sandrine Favre, Octapharma
    Head of Corporate Pharmaceutical Production.
  • Klaus Feuerhelm, Regierungspräsidium Tübingen
    GMP-Inspektor.
  • Dr. Andreas Flückiger, ehemals F.Hoffmann La-Roche
    Ehemals Leiter Gesundheitsschutz im Roche-Konzern.
  • Dr. Andreas Grummel, Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM)
    Apotheker, Wissenschaftlicher Direktor und Mitglied der BfArM PAT Gruppe.
  • Dr. Friedrich Haefele, Boehringer Ingelheim Pharma
    Head of the department Biopharma Fill & Finish Germany.
  • Dr. Martin Haerer, Rommelag CMO
    Responsible for Business Development, Technology Transfer and  Research and Development and acting as QP.
  • Thomas Hahlgans, CSL Behring
    Leiter Instandhaltungsmanagement.
  • Dr. Thilo Kaltenbach, Roland Berger (Pharma & Healthcare Competence Center)
    Senior Partner.
  • Kieran Keaney, Abbvie Ireland
    Senior Engineer.
  • Alan Kelly, Genzyme
    Mechanical engineer in the technical development department.
  • Dr. Gerald Kindermann, F. Hoffmann La-Roche
    QA and GMP Compliance Lead.
  • Peter Koop, Arvato Systems
    Vice President.
  • Dr. Johannes Krämer, CSL Behring
    Leiter des Engineerings.
  • Felix Krumbein, Roche Diagnostics
    Head of Inspections-Systems-Support.
  • Eberhard Kwiatkowski, PharmAdvantageIT
    Until 2008 responsible for the computerized systems of the Supply Center of Bayer Pharma AG in Wuppertal, as well as quality auditor for computerized systems.
  • Dr. Jean-Denis Mallet, ECA
    Former head of the French Inspection Department AFSSAPS.
  • Dr. Thomas Meindl, Labor LS
    Division Manager.
  • Didier Meyer, DMCompliance
    Consultant at DMCompliance.
  • Gerd Moelgaard, ECA Validation Interest Group
    Consultant, Moelgaard Consuliting.
  • Christian Mrotzek, Fresenius Kabi
    Senior Director Engineering and Technology.
  • Dr. Daniel Müller, Local Authority of Baden Württemberg
    Head of GMP Inspectorate.
  • Dr. Felix Oehme, Bayer
    Head of Biological Development.
  • Thomas Page, FUJIFILM Diosynth Biotechnologies
    Vice President, Engineering & Asset Development.
  • Jessica Prasser, Roche Diagnsotics
    Expertin für Biostatistics.
  • Thomas Reiner, Berndt+Partner
    CEO; Vorstandsmitglied der World Packaging Organisation.
  • Armin Rockenschaub, GE Healthcare
    Manufacturing Engineering and Quality Engineering Leader.
  • Doris Rottenbusch, Vetter Pharma-Fertigung
    Leading a team of experts in Development Service - Technology & Process Transfer.
  • Knud Ryhl, Novo Nordisk
    Senior Lead Auditor / Senior Specialist.
  • Prof. Farshid Sadeghipour, Lausanne University Hospital
    Head of Pharmacy.
  • Yves Samson, ECA Data Integrity & IT Compliance Interest Group
    Kereon AG, CEO & e-Compliance SME.
  • Dr. Ralph Sapper, Merck
    Senior Projektmanager.
  • Matthias Schaar, Novartis Pharma, Stein
    Teamleader Qualification & Infrastructure in Microbiological Department.
  • Gabriela Schallmeiner, Austrian QP Association
    Deputy Chair.
  • Dr. Ute Schleyer, Vetter Pharma Fertigung
    Project Manager, Site & Plant Development.
  • Thorsten Schlosser, Allergopharma
    Vice President Technical Operations.
  • Stefan Schoettle, Roche Diagnostics
    Head of Informatics Pharma Manufacturing Mannheim.
  • Dr. Thomas Schwarz, Novartis
    Leiter Strategische Planung.
  • Christof Specht, F. Hoffmann La-Roche
    Gesamtprojektleiter & Bauherr.
  • Dr. Clemens Stief, Pfizer
    Teamleiter Produkt- und Prozess-Entwicklung.
  • Dr. Frank Stieneker, Consultant und QP
    Produktentwicklung, Prozess- und Anlagendesign-Funktion.
  • Dr. Arno Terhechte, Bezirksregierung Münster
    Medicines Inspector.
  • Dr. Frank Thielmann, Novartis
    Operation Excellence Leader Biologics.
  • Patrick Vanhecke, GSK Vaccines
    Expert in Isolator and Aseptic Filling Technologies and Room decontamination process.
  • Martin Wenzel, Roche Diagnostics
    Gruppenleiter Technik, Clinical Supply Center.
  • Dr. Melanie Zerulla-Wernitz, Vetter Pharma-Fertigung
    Team Manager, Project & Service Analytics, Analytical Service Laboratory.
  • Jörg Zimmermann, Vetter Pharma-Fertigung
    Vice President Development Services.